BioWorld

Feb. 22, 2005

Neose Raising $28M, Planning INDs For Two Protein Products

Neose Technologies Inc. is raising $28 million in a public offering to fund ongoing development activities, including preclinical and clinical evaluation of its two lead protein products. (BioWorld Today) Read More

FDA Committee Members Vote To Let Vioxx Return To Market

Combinatorial Approach Flies Against Huntington's Disease

CNS Research Deal With Otsuka Gives Galenea Room To Grow

Holiday notice

Acusphere Raises $41.5M Via Sale Of Convertible Shares

Other News To Note

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...